Industryevents
Published October 15, 2026
Compass Pathways CEO: Psychedelics company will 'go slow before we go fast'
Read the full story at Industryevents
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to “go slow before we.
Surfaced by 2 Google Alerts
- Psychedelics
- Psychedelic biotech
